Injective (INJ) is currently priced at $3.27, reflecting a 24-hour change of -2.37%. The daily trading range has been relatively narrow, with a high of $3.37 and a low of $3.15, indicating low volatility in the short term.

Volume over the last 24 hours stands at approximately 64 million, representing about 19.57% of the market cap. This volume is substantial, suggesting active trading interest but could also indicate a lack of conviction in price direction given the recent downtrend.

The short-term moving averages show mixed signals, with the 8 SMA at $3.22 (+1.67%) and the 13 SMA at $3.24 (+0.93%) indicating slight upward momentum. In contrast, the 21 SMA at $3.26 (+0.40%) is closer to the current price, while the 55 SMA at $3.21 (+1.84%) suggests stronger support at lower levels, but the 144 SMA at $3.45 reflects a significant resistance level, down 5.29%.

The 1-hour RSI is neutral at 51, suggesting the asset is neither overbought nor oversold. However, the 7-day RSI at 47 indicates a bearish sentiment, alongside a 7-day price change of -9.19%, and a more pronounced 14-day decline of -27.93%, indicating a negative trend in the medium term.

The price has experienced a steep drop of 37.56% over the last 30 days, further confirming a bearish outlook in the near term. Given the significant distance from the all-time high of $52.62, the current price reflects a considerable correction and market sentiment shifting toward cautiousness.

Considering the current technical indicators and price trends, the overall outlook for INJ is bearish, with resistance levels proving challenging to breach. Therefore, the recommendation is to Hold, as further downside may be limited, but a clear buy signal is not present until there is a confirmed reversal in momentum and stronger buying pressure.